There are 169 resources available
35P - Beyond microsatellite testing: Tumor mutational burden, should it be routine in patients with GI cancers?
Presenter: Farrukh Djuraev
Session: Cocktail and Poster Display session
Resources:
Abstract
36P - Development of patient-derived explant model as a robust preclinical tool to predict the efficacy of ICB-based immunotherapy in colorectal cancer patients
Presenter: Hayet Rafa
Session: Cocktail and Poster Display session
Resources:
Abstract
37P - Efficacy and safety of PD-1 monoclonal antibodies in the treatment of esophageal squamous cell carcinoma: Systematic review and meta regression analysis
Presenter: Ameer Al Wssawi
Session: Cocktail and Poster Display session
Resources:
Abstract
39P - The possibility of predicting the effectiveness of treatment of soft tissue sarcomas on the basis of the properties of their immunologic microenvironment
Presenter: Nuriddin Asamedinov
Session: Cocktail and Poster Display session
Resources:
Abstract
40P - Small molecule inhibitor HI-TOPK-032 improves NK-92MI cells infiltration into ovarian tumors
Presenter: Ruiye Yang
Session: Cocktail and Poster Display session
Resources:
Abstract
41P - Unveiling the complex interplay of B7-H3, oxylipins, and immune responses in ovarian cancer microenvironment
Presenter: Mengqi Deng
Session: Cocktail and Poster Display session
Resources:
Abstract
42P - sONE and MEG3: Novel immunomodulatory tumor suppressor LncRNAs in HCV-induced hepatocellular carcinoma patients
Presenter: Rana Youness
Session: Cocktail and Poster Display session
Resources:
Abstract
46P - Dynamics of ROS1 kinase binding: Insights into DFG-out tyrosine kinase inhibitors and effects of allosteric-pocket mutations
Presenter: Farhan Haq
Session: Cocktail and Poster Display session
Resources:
Abstract
47P - Unlocking potential for enhancing anti-tumor immunity: Targeting hematopoietic progenitor kinase 1 (HPK1) with novel small molecules
Presenter: Sreevalli Sharma
Session: Cocktail and Poster Display session
Resources:
Abstract
48P - BWC5044 is a novel potent and highly selective CDK7 inhibitor that suppresses transcriptional activity and arrests the cell cycle through MYC
Presenter: Sonali Setua
Session: Cocktail and Poster Display session
Resources:
Abstract